Nanostring cosmx spatial gene expression library preparation kits

Ended Awarded Last action

Contract number
75N91024F00003
Awardee
Awarding agency
Obligated
$17,501

Award facts

Contract value 100% obligated
$17,501.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
339999 All Other Miscellaneous Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute (NCI) awarded a $17,501 firm fixed price blanket purchase agreement (BPA) call to Nanostring Technologies, Inc. for nanoString CosMx Spatial Gene Expression Library Preparation Kits. The contract, awarded on April 18, 2024, with an ultimate completion date of April 17, 2025, will be performed at the NCI facility in Bethesda, Maryland. This award carries no set-aside designation and represents a continuation of the government's procurement relationship with Nanostring, the publicly traded provider of advanced genomic analysis platforms and spatial profiling technologies.

The CosMx spatial gene expression kits enable multiplexed detection and analysis of nucleic acids across tissue samples, supporting the NCI's translational research and molecular diagnostics initiatives. Nanostring Technologies has an established track record of federal contracting with the National Institutes of Health and related agencies, having previously supplied GeoMx Digital Spatial Profiler systems, nCounter analysis equipment, reagent kits, and consumables. The vendor holds significant federal contract vehicles including a $2.8 million blanket purchase agreement with the Defense Health Agency and a $596,881 indefinite delivery/indefinite quantity contract with the USDA Agricultural Research Service, demonstrating substantial capacity to support government research programs with specialized genomic analysis tools and reagents.

Quick answers

Who was awarded contract 75N91024F00003?

75N91024F00003 was awarded to Nanostring Technologies, Inc. by National Cancer Institute (National Institutes of Health) on April 18, 2024.

How much is contract 75N91024F00003 worth?

The government has obligated $17,501 on 75N91024F00003.

Is contract 75N91024F00003 an order under another contract?

Yes. 75N91024F00003 is a BPA call under HHSN263201400050B, a blanket purchase agreement.

Was contract 75N91024F00003 competed?

The extent of competition for 75N91024F00003 was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award